Brief: Tandem Diabetes Care Q3 Gross Margin 54%
06/11/2025 21:05
Nov 06 (Reuters) - Tandem Diabetes Care Q3 operating income USD -22.9 million. Q3 net income USD -21.2 million Q3 adjusted operating income USD -22.9 million vs. IBES estimate USD -22.4 million Q3 adjusted net income USD -21.2 million vs. IBES estimate USD -21.1 million outlook FY adjusted EBITDA margin -5%
Recent news on Tandem Diabetes Care
See all newsU.S. STOCKS ON THE MOVE -VF Corp, Biogen, AbbVie
US STOCKS ON THE MOVE-SpaceX, Humana, AbbVie
U.S. STOCKS ON THE MOVE-SpaceX, Humana, Crescent Energy
MedTech growth concerns likely to overshadow Q3 results, Leerink says
Tandem Diabetes Care, Inc. reports results for the quarter ended June 30 - Earnings Summary